Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GUMM - Eliminate the Common Cold -- Ignore unavailable to you. Want to Upgrade?

To: DanZ who wrote (3374)	12/1/2000 8:19:45 AM
From: Tatnic	Read Replies (1) \| Respond to of 5582

All I know is what I see....with speculative stocks I never believe what management says. The chart doesn't lie. Short-term you could see a decent bounce from the short covering we just saw...but watch the $10 level.

To: DanZ who wrote (3374)	12/1/2000 9:34:29 AM
From: Troutbum	Respond to of 5582

Friday December 1, 7:01 am Eastern Time Press Release SOURCE: Gum Tech International Inc. Gum Tech International Announces Research And Development Agreement With Procter & Gamble PHOENIX, Dec. 1 /PRNewswire/ -- Gum Tech International Inc., (Nasdaq: GUMM - news) announced today that it has received a cash payment of $1.625 million from The Procter & Gamble Company in connection with an on-going research and development agreement between the two companies. Gum Tech will use these funds to continue research and increase manufacturing capabilities. Work continues by both parties in an effort to create commercial products from this relationship. Other terms of the research and development agreement are not being disclosed at this time. Gum Tech International, Inc. is an innovative nutrient and drug delivery technology company engaged in the development, manufacture and marketing of delivery systems for bioactive compounds. Gum Tech is the majority owner of Gel Tech LLC which markets Zicam(TM) Cold Remedy, a patented, revolutionary homeopathic remedy that significantly reduces the duration and severity of the common cold, and Zicam(TM) Allergy Relief, a homeopathic remedy designed to provide relief to allergy sufferers. For additional information, please contact Lynn Romero, Manager of Investor Relations, 602-252-1617, ext. 320, lromero@gum-tech.com. Gum Tech is located at 246 East Watkins Street, Phoenix, Arizona 85004. Gum Tech Forward Looking Statement Disclaimer: This news release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including the possible implication that the ongoing research and development efforts by Gum Tech and Procter & Gamble will result in a commercially viable product. These forward-looking statements are based on Gum Tech's expectations and are subject to a number of risks and uncertainties, many of which cannot be accurately predicted or quantified and are beyond Gum Tech's control. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying these forward-looking statements. These risks and uncertainties include the possibility that the joint research and development efforts may be unsuccessful in developing a commercially viable product, the potential that the parties anticipated schedule for developing, launching and marketing any commercial product will be delayed, perhaps significantly, the risk that Procter & Gamble could abandon the project based on factors unrelated to Gum Tech, the possibility that the development, launch, and marketing of any product may not be adequately funded, and the uncertainty that, even if a product is developed and launched it may not achieve widespread market acceptance. In addition, because there currently is no agreement between Gum Tech and Procter & Gamble defining the rights and benefits to which each party would be entitled if a commercially viable product is developed, it is premature to speculate what impact these efforts could have on Gum Tech. SOURCE: Gum Tech International Inc.

To: DanZ who wrote (3374)	12/4/2000 6:56:39 PM
From: Tatnic	Read Replies (1) \| Respond to of 5582

Who is hoping, wishing, and praying? Even based on the most modest estimates for dental gum to the large consumer products company, nicotine gum to the joint venture with Swedish Match, and Zicam in 2001, this stock is way undervalued. That doesn't even include other new products that they might introduce. It isn't a matter of hoping and wishing. It's a matter of waiting patiently for the stock to trade at a more fair valuation. A lot of stocks are trading at ridiculously low valuations. I don't think it is prudent to confuse a bad market and irrational short selling with the fair value of a company. GUMM bounced off 8 1/2 again today, closed higher on above average volume, and refused to make a new 52 week low despite a terrible overall market. I take this as a sign that the stock is unlikely to trade any lower. ============================== Dan, Rookie mistake. YOu can't, I repeat CANNOT apply your logical engineering mind to speculative stocks. Your big mistake is believing what you read, not what you see. Tough break.